MedPath

To relieve crisis pain in sickle cell anemia patients

Phase 2
Conditions
Sickle cell anemia.
Sickle-cell anaemia with crisis
Registration Number
IRCT2016072511956N6
Lead Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
84
Inclusion Criteria

use of studying medicine; no prior history of cardiovascular and respiratory diseases; not having hypertension; not using other analgesic drug.
Exclusion criteria: unwillingness to continue the study; major side-effects due to the use of medications; addicted, especially for morphine injection; having sensitivity.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain relief. Timepoint: Before and 5 minutes after intervention. Method of measurement: The visual analog scale.
Secondary Outcome Measures
NameTimeMethod
Side-effects of medications (nausea and vomiting, dizziness, respiratory depression, skin rash in the area of injection, menorrhagia after injection, hypotension, seizures, drowsiness, allergic reactions, etc). Timepoint: 5 minutes after intervention. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath